News & Views | Published:

PRECISION ONCOLOGY

Cancer cell lines as patient avatars for drug response prediction

Nature Geneticsvolume 50pages13501351 (2018) | Download Citation

Patient-derived cancer cell lines could address two major challenges in oncology: real-time drug response prediction and the creation of massive knowledge banks. A new study showcases the power of this approach for precision oncology.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    Hutter, C. & Zenklusen, J. C. Cell 173, 283–285 (2018).

  2. 2.

    Sanchez-Vega, F. et al. Cell 173, 321–337 (2018).

  3. 3.

    Iorio, F. et al. Cell 166, 740–754 (2016).

  4. 4.

    Lee, J.-K. et al. Nat. Genet. https://doi.org/10.1038/s41588-018-0209-6 (2018).

  5. 5.

    van de Wetering, M. et al. Cell 161, 933–945 (2015).

  6. 6.

    Vlachogiannis, G. et al. Science 359, 920–926 (2018).

  7. 7.

    Lee, S. H. et al. Cell 173, 515–528 (2018).

Download references

Author information

Affiliations

  1. IMED Oncology, AstraZeneca, Cambridge, UK

    • Ultan McDermott

Authors

  1. Search for Ultan McDermott in:

Competing interests

The author declares no competing interests.

Corresponding author

Correspondence to Ultan McDermott.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/s41588-018-0245-2

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing